SCHEMBL5249254

SCHEMBL5249254

COC(=O)c1cc(C2CCCC2)cc(N2CCCC2=O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.47
RAB9A P51151 6/20 0.47
SMN1; SMN2 Q16637 5/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
HPGD P15428 5/20 0.45
TSHR P16473 4/20 0.45
TP53 P04637 1/20 0.45
MAPK1 P28482 1/20 0.45
ALDH1A1 P00352 4/20 0.45
CYP2C19 P33261 2/20 0.45
CYP3A4 P08684 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
MAPT P10636 1/20 0.41
LMNA P02545 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
GAA P10253 1/20 0.41
ATM Q13315 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5249518 0.99 SMN1; SMN2 (0.49) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL5218640 0.89 MEN1 (0.45) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL5222567 0.87 ALDH1A1 (0.56) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL5218713 0.86 MEN1 (0.41) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL5226544 0.86 HPGD (0.55) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL475775 0.85 MEN1 (0.56) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL5219444 0.85 MEN1 (0.56) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL5220451 0.82 MEN1 (0.42) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL5222411 0.82 MEN1 (0.41) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL5221306 0.81 ALDH1A1 (0.58) NPC1RAB9ASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed